Malta - English - Medicines Authority

meda pharmaceuticals limited - azelastine hydrochloride; fluticasone propionate - nasal spray, suspension - azelastine hydrochloride 137 µg; fluticasone propionate 50 µg - nasal preparations

Malta - English - Medicines Authority

meda pharmaceuticals limited - azelastine hydrochloride; fluticasone propionate - nasal spray, suspension - azelastine hydrochloride 137 µg; fluticasone propionate 50 µg - nasal preparations

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - azelastine hydrochloride, quantity: 0.5 mg/ml (equivalent: azelastine, qty 0.457 mg/ml) - eye drops - excipient ingredients: sodium hydroxide; benzalkonium chloride; water for injections; disodium edetate; hypromellose; sorbitol solution (70 per cent) (crystallising) - eyezep is indicated for the treatment and prevention of the symptoms of seasonal and non-seasonal (perennial) allergic conjunctivitis in adults and children 4 years and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - azelastine hydrochloride 0.5 mg/ml;   - eye drops, solution - 0.5 mg/ml - active: azelastine hydrochloride 0.5 mg/ml   excipient: disodium edetate hypromellose sodium hydroxide sorbitol water for injection - allergic conjunctivitus

Malta - English - Medicines Authority

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - azelastine hydrochloride, fluticasone propionate - nasal spray, suspension - azelastine hydrochloride 137 µg/spray fluticasone propionate 50 µg/spray - nasal preparations

Malta - English - Medicines Authority

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - azelastine hydrochloride, fluticasone propionate - nasal spray, suspension - azelastine hydrochloride 137 µg fluticasone propionate 50 µg - nasal preparations

Malta - English - Medicines Authority

ursapharm arzeneitmittel gmbh industriestrasse, 66129 saarbrucken, germany - azelastine hydrochloride - eye drops, solution - azelastine hydrochloride 0.05 % - ophthalmologicals

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - azelastine hydrochloride 1 mg/g ((137 micrograms/spray)); fluticasone propionate 0.365 mg/g ((50 micrograms/spray)) - nasal spray suspension - active: azelastine hydrochloride 1 mg/g ((137 micrograms/spray)) fluticasone propionate 0.365 mg/g ((50 micrograms/spray)) excipient: benzalkonium chloride disodium edetate glycerol microcrystalline cellulose and carmellose sodium nitrogen phenethyl alcohol polysorbate 80 purified water - symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluticasone propionate, quantity: 50 microgram/actuation; azelastine hydrochloride, quantity: 137 microgram/actuation (equivalent: azelastine, qty 125 microgram/actuation) - spray, nasal - excipient ingredients: phenethyl alcohol; benzalkonium chloride; purified water; microcrystalline cellulose; polysorbate 80; carmellose sodium; glycerol; disodium edetate - symptomatic treatment of moderate to severe allergic rhinitis for up to 6 months.

Australia - English - Department of Health (Therapeutic Goods Administration)

ent technologies pty ltd - azelastine hydrochloride, quantity: 1 mg/ml - spray, nasal - excipient ingredients: sodium chloride; water for injections; disodium edetate; hypromellose; citric acid; dibasic sodium phosphate dodecahydrate - for the symptomatic treatment of seasonal allergic rhinitis and perennial allergic rhinitis.